&quot;Today at 10:55 a.m. PST, @preeyakgupta discusses the potential efﬁcacy of our lead drug candidate, AZR-MD-001, in restoring gland function and improving signs and ocular symptoms of Meibomian Gland Dysfunction. #ophthalmology #visionresearch #ASCRS2023&quot;